Mintardjo R - Search Results

1

Impact of recombinant adenovirus serotype 35 priming versus boosting of a Plasmodium falciparum protein: characterization of T- and B-cell responses to liver-stage antigen 1.

Rodríguez A, Goudsmit J, Companjen A, Mintardjo R, Gillissen G, Tax D, Sijtsma J, Weverling GJ, Holterman L, Lanar DE, Havenga MJ, Radosevic K. Rodríguez A, et al. Among authors: mintardjo r. Infect Immun. 2008 Apr;76(4):1709-18. doi: 10.1128/IAI.01614-07. Epub 2008 Jan 22. Infect Immun. 2008. PMID: 18212075 Free PMC article.

2

Expression and immunogenicity of the Plasmodium falciparum circumsporozoite protein: the role of GPI signal sequence.

Ophorst OJ, Radosević K, Ouwehand K, van Beem W, Mintardjo R, Sijtsma J, Kaspers J, Companjen A, Holterman L, Goudsmit J, Havenga MJ. Ophorst OJ, et al. Among authors: mintardjo r. Vaccine. 2007 Feb 9;25(8):1426-36. doi: 10.1016/j.vaccine.2006.10.050. Epub 2006 Nov 7. Vaccine. 2007. PMID: 17161889

3

Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon.

Radosevic K, Wieland CW, Rodriguez A, Weverling GJ, Mintardjo R, Gillissen G, Vogels R, Skeiky YA, Hone DM, Sadoff JC, van der Poll T, Havenga M, Goudsmit J. Radosevic K, et al. Among authors: mintardjo r. Infect Immun. 2007 Aug;75(8):4105-15. doi: 10.1128/IAI.00004-07. Epub 2007 May 25. Infect Immun. 2007. PMID: 17526747 Free PMC article.

4

Increased immunogenicity of recombinant Ad35-based malaria vaccine through formulation with aluminium phosphate adjuvant.

Ophorst OJ, Radosević K, Klap JM, Sijtsma J, Gillissen G, Mintardjo R, van Ooij MJ, Holterman L, Companjen A, Goudsmit J, Havenga MJ. Ophorst OJ, et al. Among authors: mintardjo r. Vaccine. 2007 Aug 29;25(35):6501-10. doi: 10.1016/j.vaccine.2007.06.019. Epub 2007 Jun 29. Vaccine. 2007. PMID: 17646036

5

Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvants.

Radosević K, Rodriguez A, Mintardjo R, Tax D, Bengtsson KL, Thompson C, Zambon M, Weverling GJ, Uytdehaag F, Goudsmit J. Radosević K, et al. Among authors: mintardjo r. Vaccine. 2008 Jul 4;26(29-30):3640-6. doi: 10.1016/j.vaccine.2008.04.071. Epub 2008 May 15. Vaccine. 2008. PMID: 18514980

6

Evaluation of a prime-boost vaccine schedule with distinct adenovirus vectors against malaria in rhesus monkeys.

Rodríguez A, Mintardjo R, Tax D, Gillissen G, Custers J, Pau MG, Klap J, Santra S, Balachandran H, Letvin NL, Goudsmit J, Radosević K. Rodríguez A, et al. Among authors: mintardjo r. Vaccine. 2009 Oct 19;27(44):6226-33. doi: 10.1016/j.vaccine.2009.07.106. Epub 2009 Aug 15. Vaccine. 2009. PMID: 19686691

7

Novel replication-incompetent adenoviral B-group vectors: high vector stability and yield in PER.C6 cells.

Havenga M, Vogels R, Zuijdgeest D, Radosevic K, Mueller S, Sieuwerts M, Weichold F, Damen I, Kaspers J, Lemckert A, van Meerendonk M, van der Vlugt R, Holterman L, Hone D, Skeiky Y, Mintardjo R, Gillissen G, Barouch D, Sadoff J, Goudsmit J. Havenga M, et al. Among authors: mintardjo r. J Gen Virol. 2006 Aug;87(Pt 8):2135-2143. doi: 10.1099/vir.0.81956-0. J Gen Virol. 2006. PMID: 16847108

8

Human CD46-transgenic mice in studies involving replication-incompetent adenoviral type 35 vectors.

Verhaagh S, de Jong E, Goudsmit J, Lecollinet S, Gillissen G, de Vries M, van Leuven K, Que I, Ouwehand K, Mintardjo R, Weverling GJ, Radošević K, Richardson J, Eloit M, Lowik C, Quax P, Havenga M. Verhaagh S, et al. Among authors: mintardjo r. J Gen Virol. 2006 Feb;87(Pt 2):255-265. doi: 10.1099/vir.0.81293-0. J Gen Virol. 2006. PMID: 16432010

9

Whole-body bioluminescent imaging of human uveal melanoma in a new mouse model of local tumor growth and metastasis.

Notting IC, Buijs JT, Que I, Mintardjo RE, van der Horst G, Karperien M, Missotten GS, Jager MJ, Schalij-Delfos NE, Keunen JE, van der Pluijm G. Notting IC, et al. Among authors: mintardjo re. Invest Ophthalmol Vis Sci. 2005 May;46(5):1581-7. doi: 10.1167/iovs.04-0245. Invest Ophthalmol Vis Sci. 2005. PMID: 15851554

10

Bone morphogenetic protein 7 inhibits tumor growth of human uveal melanoma in vivo.

Notting I, Buijs J, Mintardjo R, van der Horst G, Vukicevic S, Lowik C, Schalij-Delfos N, Keunen J, van der Pluijm G. Notting I, et al. Among authors: mintardjo r. Invest Ophthalmol Vis Sci. 2007 Nov;48(11):4882-9. doi: 10.1167/iovs.07-0505. Invest Ophthalmol Vis Sci. 2007. PMID: 17962434

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters